A Vibrio parahaemolyticus T3SS Effector Mediates Pathogenesis by Independently Enabling Intestinal Colonization and Inhibiting TAK1 Activation

Cell Reports

Volumn 3, Issue 5, 2013, Pages 1690-1702

  Zhou, Xiaohui ^a,b,c,d   Gewurz, BenjaminE ^a,b,d   Ritchie, JenniferM ^a,b,c   Takasaki, Kaoru ^a   Greenfeld, Hannah ^a   Kieff, Elliott ^a,b   Davis, BrigidM ^a,b,c   Waldor, MatthewK ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL PROTEIN; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; ENZYME ACTIVATION; ENZYME ACTIVITY; HELA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RABBIT; TWO DIMENSIONAL GEL ELECTROPHORESIS; TYPE III SECRETION SYSTEM; VIBRIO PARAHAEMOLYTICUS; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; HUMAN; INTESTINE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHOSPHORYLATION; SECRETION (PROCESS); SIGNAL TRANSDUCTION; VIBRIOSIS;

VIBRIO PARAHAEMOLYTICUS;

ANIMALS; BACTERIAL PROTEINS; CELL LINE; HEK293 CELLS; HELA CELLS; HUMANS; INTERLEUKIN-8; INTESTINES; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; PHOSPHORYLATION; RABBITS; SIGNAL TRANSDUCTION; TRANSFECTION; VIBRIO INFECTIONS; VIBRIO PARAHAEMOLYTICUS; VIRULENCE FACTORS;

EID: 84878557823     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.03.039     Document Type: Article

References (52)

1. Akeda Y., Kodama T., Saito K., Iida T., Oishi K., Honda T. Identification of the Vibrio parahaemolyticus type III secretion system 2-associated chaperone VocC for the T3SS2-specific effector VopC. FEMS Microbiol. Lett. 2011, 324:156-164.
2. Baldwin A.S. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer. Immunol. Rev. 2012, 246:327-345.
3. Bhattacharjee R.N., Park K.S., Kumagai Y., Okada K., Yamamoto M., Uematsu S., Matsui K., Kumar H., Kawai T., Iida T., et al. VP1686, a Vibrio type III secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition. J.Biol. Chem. 2006, 281:36897-36904.
4. Broberg C.A., Calder T.J., Orth K. Vibrio parahaemolyticus cell biology and pathogenicity determinants. Microbes Infect. 2011, 13:992-1001.
5. Burdette D.L., Yarbrough M.L., Orvedahl A., Gilpin C.J., Orth K. Vibrio parahaemolyticus orchestrates a multifaceted host cell infection by induction of autophagy, cell rounding, and then cell lysis. Proc. Natl. Acad. Sci. USA 2008, 105:12497-12502.
6. Burdette D.L., Yarbrough M.L., Orth K. Not without cause: Vibrioparahaemolyticus induces acute autophagy and cell death. Autophagy 2009, 5:100-102.
7. Coburn B., Sekirov I., Finlay B.B. Type III secretion systems and disease. Clin. Microbiol. Rev. 2007, 20:535-549.
8. Cornelis G.R. The type III secretion injectisome. Nat. Rev. Microbiol. 2006, 4:811-825.
9. Dai L., Aye Thu C., Liu X.Y., Xi J., Cheung P.C. TAK1, more than just innate immunity. IUBMB Life 2012, 64:825-834.
10. Dean P. Functional domains and motifs of bacterial type III effector proteins and their roles in infection. FEMS Microbiol. Rev. 2011, 35:1100-1125.
11. DeVinney R., Stein M., Reinscheid D., Abe A., Ruschkowski S., Finlay B.B. Enterohemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated. Infect. Immun. 1999, 67:2389-2398.
12. Galán J.E. Common themes in the design and function of bacterial effectors. Cell Host Microbe 2009, 5:571-579.
13. Gewurz B.E., Mar J.C., Padi M., Zhao B., Shinners N.P., Takasaki K., Bedoya E., Zou J.Y., Cahir-McFarland E., Quackenbush J., Kieff E. Canonical NF-kappaB activation is essential for Epstein-Barr viruslatent membrane protein 1 TES2/CTAR2 gene regulation. J.Virol. 2011, 85:6764-6773.
14. Gewurz B.E., Towfic F., Mar J.C., Shinners N.P., Takasaki K., Zhao B., Cahir-McFarland E.D., Quackenbush J., Xavier R.J., Kieff E. Genome-wide siRNA screen for mediators of NF-κB activation. Proc. Natl. Acad. Sci. USA 2012, 109:2467-2472.
15. Hayden M.S., Ghosh S. NF-κB in immunobiology. Cell Res. 2011, 21:223-244.
16. Hayden M.S., Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.
17. Hiyoshi H., Kodama T., Iida T., Honda T. Contribution of Vibrio parahaemolyticus virulence factors to cytotoxicity, enterotoxicity, and lethality in mice. Infect. Immun. 2010, 78:1772-1780.
18. Hiyoshi H., Kodama T., Saito K., Gotoh K., Matsuda S., Akeda Y., Honda T., Iida T. VopV, an F-actin-binding type III secretion effector, is required for Vibrio parahaemolyticus-induced enterotoxicity. Cell Host Microbe 2011, 10:401-409.
19. Hoffmann E., Dittrich-Breiholz O., Holtmann H., Kracht M. Multiple control of interleukin-8 gene expression. J.Leukoc. Biol. 2002, 72:847-855.
20. Kajino T., Ren H., Iemura S.I., Natsume T., Stefansson B., Brautigan D.L., Matsumoto K., Ninomiya-Tsuji J. Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway. J.Biol. Chem. 2006, 281:39891-39896.
21. Kajino-Sakamoto R., Inagaki M., Lippert E., Akira S., Robine S., Matsumoto K., Jobin C., Ninomiya-Tsuji J. Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J.Immunol. 2008, 181:1143-1152.
22. Kajino-Sakamoto R., Omori E., Nighot P.K., Blikslager A.T., Matsumoto K., Ninomiya-Tsuji J. TGF-beta-activated kinase 1 signaling maintains intestinal integrity by preventing accumulation of reactive oxygen species in the intestinal epithelium. J.Immunol. 2010, 185:4729-4737.
23. Kelley L.A., Sternberg M.J.E. Protein structure prediction on the Web: a case study using the Phyre server. Nat. Protoc. 2009, 4:363-371.
24. Kishimoto K., Matsumoto K., Ninomiya-Tsuji J. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J.Biol. Chem. 2000, 275:7359-7364.
25. Kodama T., Rokuda M., Park K.-S., Cantarelli V.V., Matsuda S., Iida T., Honda T. Identification and characterization of VopT, a novel ADP-ribosyltransferase effector protein secreted via the Vibrio parahaemolyticus type III secretion system 2. Cell. Microbiol. 2007, 9:2598-2609.
26. Kodama T., Hiyoshi H., Gotoh K., Akeda Y., Matsuda S., Park K.S., Cantarelli V.V., Iida T., Honda T. Identification of two translocon proteins of Vibrio parahaemolyticus type III secretion system 2. Infect. Immun. 2008, 76:4282-4289.
27. Liverman A.D.B., Cheng H.-C., Trosky J.E., Leung D.W., Yarbrough M.L., Burdette D.L., Rosen M.K., Orth K. Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc. Natl. Acad. Sci. USA 2007, 104:17117-17122.
28. Luftig M., Yasui T., Soni V., Kang M.S., Jacobson N., Cahir-McFarland E., Seed B., Kieff E. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proc. Natl. Acad. Sci. USA 2004, 101:141-146.
29. Makino K., Oshima K., Kurokawa K., Yokoyama K., Uda T., Tagomori K., Iijima Y., Najima M., Nakano M., Yamashita A., et al. Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet 2003, 361:743-749.
30. Matlawska-Wasowska K., Finn R., Mustel A., O'Byrne C.P., Baird A.W., Coffey E.T., Boyd A. The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis. BMC Microbiol. 2010, 10:329.
31. Meinzer U., Barreau F., Esmiol-Welterlin S., Jung C., Villard C., Léger T., Ben-Mkaddem S., Berrebi D., Dussaillant M., Alnabhani Z., et al. Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe 2012, 11:337-351.
32. Mittal R., Peak-Chew S.Y., McMahon H.T. Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. USA 2006, 103:18574-18579.
33. Morales V.M., Bäckman A., Bagdasarian M. A series of wide-host-range low-copy-number vectors that allow direct screening for recombinants. Gene 1991, 97:39-47.
34. Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., Orth K. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 2006, 312:1211-1214.
35. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
36. Omori E., Inagaki M., Mishina Y., Matsumoto K., Ninomiya-Tsuji J. Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species. Proc. Natl. Acad. Sci. USA 2012, 109:3365-3370.
37. Paquette N., Conlon J., Sweet C., Rus F., Wilson L., Pereira A., Rosadini C.V., Goutagny N., Weber A.N., Lane W.S., et al. Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc. Natl. Acad. Sci. USA 2012, 109:12710-12715.
38. Park K.S., Ono T., Rokuda M., Jang M.H., Okada K., Iida T., Honda T. Functional characterization of two type III secretion systems of Vibrio parahaemolyticus. Infect. Immun. 2004, 72:6659-6665.
39. Piñeyro P., Zhou X., Orfe L.H., Friel P.J., Lahmers K., Call D.R. Development of two animal models to study the function of Vibrio parahaemolyticus type III secretion systems. Infect. Immun. 2010, 78:4551-4559.
40. Qadri F., Alam M.S., Nishibuchi M., Rahman T., Alam N.H., Chisti J., Kondo S., Sugiyama J., Bhuiyan N.A., Mathan M.M., et al. Adaptive and inflammatory immune responses in patients infected with strains of Vibrio parahaemolyticus. J.Infect. Dis. 2003, 187:1085-1096.
41. Ritchie J.M., Rui H., Zhou X., Iida T., Kodoma T., Ito S., Davis B.M., Bronson R.T., Waldor M.K. Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea. PLoS Pathog. 2012, 8:e1002593.
42. Rüssmann H., Shams H., Poblete F., Fu Y., Galán J.E., Donis R.O. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998, 281:565-568.
43. Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol. Sci. 2012, 33:522-530.
44. Shimohata T., Takahashi A. Diarrhea induced by infection of Vibrio parahaemolyticus. J.Med. Invest. 2010, 57:179-182.
45. Su Y.C., Liu C. Vibrio parahaemolyticus: a concern of seafood safety. Food Microbiol. 2007, 24:549-558.
46. Sun S.C. non-canonical NF-κB signaling pathway. Cell Res. 2011, 21:71-85.
47. Trosky J.E., Li Y., Mukherjee S., Keitany G., Ball H., Orth K. VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases. J.Biol. Chem. 2007, 282:34299-34305.
48. Zhang L., Ding X., Cui J., Xu H., Chen J., Gong Y.-N., Hu L., Zhou Y., Ge J., Lu Q., et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation. Nature 2012, 481:204-208.
49. Zhou X., Shah D.H., Konkel M.E., Call D.R. Type III secretion system 1 genes in Vibrio parahaemolyticus are positively regulated by ExsA and negatively regulated by ExsD. Mol. Microbiol. 2008, 69:747-764.
50. Zhou X., Konkel M.E., Call D.R. Vp1659 is a Vibrio parahaemolyticus type III secretion system 1 protein that contributes to translocation of effector proteins needed to induce cytolysis, autophagy, and disruption of actin structure in HeLa cells. J.Bacteriol. 2010, 192:3491-3502.
51. Zhou X., Nydam S.D., Christensen J.E., Konkel M.E., Orfe L., Friel P., Call D.R. Identification of potential type III secretion proteins via heterologous expression of Vibrio parahaemolyticus DNA. Appl. Environ. Microbiol. 2012, 78:3492-3494.
52. Zhou X., Ritchie J.M., Hiyoshi H., Iida T., Davis B.M., Waldor M.K., Kodama T. The hydrophilic translocator for Vibrio parahaemolyticus, T3SS2, is also translocated. Infect. Immun. 2012, 80:2940-2947.